ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1505

Evaluation Of a Case Ascertainment Tool For Ankylosing Spondylitis and Axial Spondylarthritis Among All Referrals To General Rheumatology Clinics

Eswar Krishnan1, Michael H. Weisman2, Atul A. Deodhar3, Linjun Chen1 and Lianne S. Gensler4, 1Medicine, Stanford University, Palo Alto, CA, 2Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 3Div of Arthritis & Rheum OP-09, Oregon Health & Science University, Portland, OR, 4Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Several strategies for distinguishing Ankylosing Spondylitis (AS) and Axial Spondylarthritis (axSpA) from other conditions have been proposed but have only been studied in the context of chronic back pain. Prior strategies have not been evaluated in the context of an unselected rheumatologic population where the prevalence is lower and/or in older age groups. This study evaluates a psychometrically distinct patient questionnaire in an unselected population that includes patients without back pain and those with fibromyalgia.

Methods: The study comprised of 490 consecutive, unselected new patients referred to 4 academic rheumatology outpatient clinics in the period 2011-12. Patients completed a questionnaire prior to clinical evaluation. Inability to obtain informed consent in the English language was the only exclusion criterion. Patients were followed for 6 months from the baseline visit. Protocol specified gold standard for AS and axSpA diagnosis was the rheumatologist assessment (blinded to the results of the questionnaire) based on the history, physical examination, radiographs, and laboratory testing and appropriate work up. Questionnaire summary scores were converted to Z-scores.

Results: The mean (range) age of the study population was 48 (18-91) years; 74% were women. Of the 490 patients 102 tested positive by the questionnaire using original cut off values and 22 received a rheumatologist diagnosis of AS (prevalence 4.4%) and 36 were diagnosed with axSpA (prevalence =7.4%). Results of ROC analyses are shown in Table 1. The areas under the curve for AS and axSpA for patients with and without back pain were 0.74, 0.67, 0.84,0.75 respectively

Table 1. Receiver Operator Curve Analysis for patients with AS and axSpA with and without back pain

Z-score cut off

AS

Axial SpA

Sen

Spec

Sen

Spec

All patients

>=-1

95

18

86

17

>=0

86

41

72

41

>=1

36

91

39

90

Patients with Back pain

>=-1

95

31

89

31

>=0

85

70

69

71

>=1

40

91

38

91

Sen: Sensitivity (%); Spec:Specificity (%)

Conclusion: With adjustments to the score cut-offs, the evaluated patient questionnaire may be used either as a sensitive screening tool or as a specific diagnostic aid in assessing AS and axSpA in non-selected patient populations.

 


Disclosure:

E. Krishnan,

UCB Pharmaceuticals,

2;

M. H. Weisman,

UCB Pharmaceuticals,

9;

A. A. Deodhar,

UCB Pharmaceuticals,

9;

L. Chen,

UCB Pharmaceuticals,

9;

L. S. Gensler,

UCB Pharmaceuticals,

9.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-a-case-ascertainment-tool-for-ankylosing-spondylitis-and-axial-spondylarthritis-among-all-referrals-to-general-rheumatology-clinics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology